The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 16, 2018

Filed:

Apr. 13, 2015
Applicant:

Pfizer Inc., New York, NY (US);

Inventors:

David Lawrence Firman Gray, Groton, MA (US);

Lei Zhang, Auburndale, MA (US);

Jennifer Elizabeth Davoren, Cambridge, MA (US);

Amy Beth Dounay, Colorado Springs, CO (US);

Ivan Viktorovich Efremov, Brookline, MA (US);

Chewah Lee, Wallingford, CT (US);

Scot Richard Mente, Arlington, MA (US);

Steven Victor O'Neil, East Lyme, CT (US);

Bruce Nelsen Rogers, Belmont, MA (US);

Chakrapani Subramanyam, South Glastonbury, CT (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); C07D 491/048 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 491/048 (2013.01); C07D 471/04 (2013.01); C07D 498/04 (2013.01);
Abstract

The present invention provides, in part, compounds of Formula (I) and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), schizotypal personality disorder, cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), ADHD, Parkinson's disease, anxiety, and depression.


Find Patent Forward Citations

Gray, David Lawrence Firman. (2018). Heteroaromatic compounds and their use as dopamine d1 ligands (U.S. Patent No. 9868744). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9868744

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…